N/A N=61 Eating Behaviour in Crohn's Disease
Crohn's Disease
Primary: Dietary Recalls (Calorific Intake) — 1900.9; 2054.3 kcal
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=399 Nutrition in Gastroenteropancreatic Neuroendocrine Tumor
Gastroenteropancreatic Neuroendocrine Tumor
Primary: Prevalence of Malnutrition in GEP NET — 247; 152 Participants
N/A N=15 Cancer Anorexia and the Central Nervous System
Cancer Cachexia
Primary: ACTIVATION/NON ACTIVATION OF SPECIFIC BRAIN AREAS, EVALUATED BY FUNCTIONAL MAGNETIC RESONANCE — 585.57; 667.92; 511.22 BOLD
N/A N=600 Evaluating Oral Nutritional Supplements on Children's Nutritional Status and Digestive Health in Vietnam.
Undernutrition · Wasting · Malnourished
Primary: Improvement of Digestive Disorders and Anorexia Nervosa — 219; 212; 175; 155 participants
Phase 3 N=73 Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients
Gastrointestinal Cancer · Lung Cancer
Primary: Change in Appetite as Measured by ESAS — -0.83; -1.19 units on a scale
N/A N=42 The Impact of Snacks Which Vary Nutritionally in Their Satiating Potential on Measures of Appetite Control
Lack of Satiety · Hyperphagia
Primary: Test Meal Energy Intake — 1007.3; 1019.6; 1143.4 kcal — p=<0.01
Phase 2 N=5 Ghrelin Dose Finding In Frail Elderly
The Frailty Syndrome
Primary: Treatment Emergent Adverse Events — 1; 0; 1; 0 Events
N/A N=16 The Role of Altered Nutrient Partitioning in Food Reward
Overweight and Obesity
Primary: Change in Preference- Liking — 6.5; 4.5 units on a scale
N/A N=127 Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia
Oropharyngeal Dysphagia
Primary: Adequacy of Oral Intake of Energy — 41; 36 kcal/kg/d
N/A N=99 Fear, Gastrointestinal Distress, and Interoception: Physiological and Psychological Mechanisms in Eating Disorders
Feeding and Eating Disorders
Primary: Subjective Rating of Fear — -36.9444; -23.9219; -47.3611; 85.6250 units on scale*minutes — p=.879
N/A N=152 Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa
Anorexia Nervosa
Primary: Rate of Weight Change — 0.095; 0.260 kg/m^2 per month
Phase 1 N=18 Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Non-small Cell Lung Cancer · Pancreatic Cancer · Colorectal Cancer
Primary: Change From Baseline in Cancer-Related Cachexia Symptom Assessment in Appetite Score at Week 4 in Part A — 2.45; 1.84 Units on a Scale
N/A N=5 Gastrectomy, Eating Behaviour and GLP-1
Gastric Cancer · Dumping Syndrome
Primary: Nadir Blood Glucose — 3; 4.4 mmol/l — p=0.008
N/A N=39 The Effect of Protein-enriched Diet on Body Composition and Appetite
Overweight · Obese · Metabolic Syndrome
Primary: Change in Lipid Content of the Liver (Intrahepatocellular Lipid) — 27.9; 9.3; 21.4; 5.9 % IHCL — p=<0.05
N/A N=46 Activity, Adiposity, and Appetite in Adolescents 2
Obesity · Metabolic Disease · Insulin Sensitivity
Primary: Appetite- Subjective — 9239.4; 7879.6; 6130.5; 8970.0 score on a scale*min
Phase 2 N=10 Ghrelin in Healthy and Frail Older Women
Frailty
Primary: Kilocalories Consumed — 412; 553 Kilocalorie
Phase 2 N=5 Ghrelin Repeated Dose Study
Frailty in Aging
Primary: Safety — 4 participants
N/A N=36 Nutritional Status and Enteral Absorption Capability After Brain Death
Brain Death
Primary: Primary Outcome Measure is IL-6 Level — 565.5; 264.9 pg/ml
N/A N=32 Appetite Suppression Trial With Polydextrose
Body Weight · Non-restrained Eaters
Primary: Energy Intake at an ad Libitum Lunch on a Test-day in Normal Weight and Overweight Women. — 2694; 2537; 2317; 2335 kJ — p=0.2918
Phase 2 N=40 Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects
Obesity; Overweight
Primary: Food Consumption — 605.5; 404.3; 423.6 weight food eaten g
N/A N=35 The Consumption of Beef on Appetite and Cognitive Function
Obesity · Poor Glycemic Control · Dietary Interventions
Primary: Daily Energy Intake: Total Daily Intake — 2859; 2313; 2714; 2396 kcal
N/A N=10 Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
Prader-Willi Syndrome
Primary: Change in Weight — -.5 kg — p=.07
N/A N=60 A Short-Term Appetite Suppression Trial Using Appethyl™: The Pizza
Overweight · Obesity
Primary: Difference in Pizza Consumed During Two Meals — 1020.21; 1067.46 calories — p=>0.05
Phase 2 N=34 Olanzapine in the Treatment of Patients With Anorexia Nervosa
Anorexia Nervosa
Primary: Body Mass Index (BMI) (kg/m^2) — 19.66; 20.30; 19.66; 20.30 kg/m^2
N/A N=34 COPD: Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks.
Malnutrition
Primary: Weight Changes — 2.3; 4.4 kg
N/A N=47 Nutritional Intake of "Finger-food" on Elderly People in Seniors's Resident
Nutritive Value
Primary: Quantitative Measure of Ingesta — 941.1; 910.1; 1001; 862.9 Kilocalories — p=<0.0001
N/A N=60 The Effectiveness and Mechanism Study of Auricular Needling in Treating Cancer Induced Anorexia
Anorexia Nervosa · Cancer
Primary: Simple Appetite Questionnaire — 8.7; 9.57; 11.26; 9.93 score on a scale
N/A N=26 Fatty Acid Oxidation Disorders & Body Weight Regulation Grant
Trifunctional Protein Deficiency
Primary: An Outcome of This Study is the Difference in Percent Body Fat (%BF) Between Subjects With a Long-chain Fatty Acid Oxidation Disorder and Normal Controls. — 31.8; 27.2…
Phase 3 N=292 Functional Dyspepsia Treatment Trial
Dyspepsia and Other Specified Disorders of Function of Stomach
Primary: Self-Report of Adequate Relief of Dyspepsia (Yes/No) For at Least 50% of Weeks 3 -12 of Treatment — 53; 38; 40 percentage of participants — p=0.05
N/A N=30 Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents
Obesity
Primary: Peak Growth Hormone (GH) on the GH Stimulation Test — 40.1; 25.2 ng/ml — p=<0.05